Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.1.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.1.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.1.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.36ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.36ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.36ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.36NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.1.1.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.1.1.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.1.1.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BM.1.1.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.12ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.12ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.12ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.12NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.5.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.5.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.18ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.18ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.18ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.18NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BN.1.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-3779.06China
BN.1.3.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
HH.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
HH.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
HH.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
KN.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
KN.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
KN.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
KN.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.43.1 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.43.1 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.43.1 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.43.1 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
B.1.1.332ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
B.1.1.332ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.332ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.332NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used